Results 171 to 180 of about 9,527 (221)

Febuxostat inhibits TGF‑β1‑induced epithelial‑mesenchymal transition via downregulation of USAG‑1 expression in Madin‑Darby canine kidney cells in�vitro

, 2019
Linghong Lu, Jiajun Zhu, Yaqian Zhang, Yanxia Wang, Shu Zhang, Anzhou Xia   +5 more
openalex   +2 more sources

Comparative risk of retinal microvascular disorders in patients with gout initiating febuxostat versus allopurinol: a population-based cohort study. [PDF]

Sci Rep
Kim MJ, Pyo JY, Choi SR, Shin A, Choung H, Ha YJ, Lee YJ, Lee EB, Kang EH.   +8 more
europepmc   +1 more source

Xanthine Oxidase-Dependent Activation of NLPR3 Inflammasome in Epithelial Cells Sustains Inflammation in Inflammatory Bowel Disease. [PDF]

Inflamm Bowel Dis
Di Petrillo A, Fais A, Raho N, Era B, Cannea FB, Padiglia A, Grecu E, Murtas D, Maxia C, Sogos V, Porcedda C, Caboni P, Demurtas M, Favale A, Onali S, Fantini MC.   +15 more
europepmc   +1 more source

Cathodic Stripping Voltammetric Determination of Febuxostat in Pharmaceutical Dosage Form and Plasma Samples

, 2016
Ibrahim H.I. Habib, M. Rizk, Maha M. Abou El‐Alamin, G S Imam   +3 more
openalex   +1 more source

Time Trends and Predictors of Gout Remission Over 6 Years. [PDF]

Arthritis Care Res (Hoboken)
Tabi-Amponsah AD, Stewart S, Gamble G, Stamp LK, Taylor WJ, Dalbeth N.   +5 more
europepmc   +1 more source

A systematic review and network meta-analysis of cardiovascular safety of benzbromarone compared to febuxostat and allopurinol in patients with gout. [PDF]

Front Cardiovasc Med
Lin TS, Lin YL, Hsu CH, Hsieh SC, Shau WY, Yang WS, Chen CL.   +6 more
europepmc   +1 more source

Impact of Urate-Lowering Agents on Renal Outcomes in Chronic Kidney Disease: A Systematic Review. [PDF]

Cureus
Gafar Abubakir Osman H, Abderahim A, Ahmed Babiker MM, Mohammed Saied MH, Abdelrahman Elsheikh EE, Mohamed Mahmoud AE, Mohamed Ali HK.   +6 more
europepmc   +1 more source

Successful Treatment of Refractory Gout Using Combined Therapy Consisting of Febuxostat and Allopurinol in a Patient with Chronic Renal Failure

, 2014
Michitaka Maekawa, Hidetaka Tomida, Takafumi Aoki, Manabu Hishida, Takatoshi Morinaga, Hirofumi Tamai   +5 more
openalex   +2 more sources

Hyperuricemia in Chronic Kidney Disease: Emerging Pathophysiology and a Novel Therapeutic Strategy. [PDF]

Int J Mol Sci
Takata T, Mae Y, Hoi S, Iyama T, Isomoto H.   +4 more
europepmc   +1 more source

Cardiovascular outcomes of febuxostat and allopurinol: A long-term Taiwanese nationwide cohort study

Tsung‐Lin Yang, Hsin‐Bang Leu, Shing-Jong Lin, Jiun‐Lin Horng, Chun-Ming Shih   +4 more
openalex   +1 more source